Please assess the completion status of the following clinical trial:

Trial Title: VitalScan MCG Rule-out Multi-centre Pivotal Study - US

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient presents to the ED with chest pain syndrome of suspected cardiac origin (i.e. symptoms consistent with ACS)~* 18+ year old male or female~* Patient is willing and able to give written informed consent~Exclusion Criteria:~* ST-segment Elevation MI (STEMI)~* Clear non-ischemic cause for symptoms (e.g. trauma)~* Hemodynamic instability on admission (e.g. BP\>220mmHg systolic \& \>110mmHg diastolic, \<80mmHg systolic \& \<40mmHg diastolic, HR\>160bpm)~* Ventricular tachycardia or fibrillation that cannot be treated effectively~* Atrial fibrillation~* Thoracic metal implants~* Pacemaker or internal defibrillator~* Pregnancy (if after 20-week period)\* or lactation~* Patient unable to lie down (i.e. supine position) or stay still on the examination bed~* Patient unable to understand the informed consent process and/or has a poor understanding of English (e.g. English- speaking relative/translator not available)~* Patient unable to comply with the requirements of the protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chest pain patients presenting to the ED (Type: None): All patients that present to the emergency department with chest pain and potentially other symptoms consistent with ACS and meet all eligibility criteria will undergo VitalScan Magnetocardiograph.

Based on this trial design, predict the completion outcome and termination type (if applicable).